FUSIP1 Activators represent a diverse group of chemical compounds that can influence the activity or expression of the FUSIP1 protein, also known as SRSF10. This class of compounds interacts primarily with the cellular splicing machinery, a critical part of gene expression where introns are removed from pre-mRNA molecules and exons are joined together to produce mature mRNA. Many of the compounds in this category target the spliceosome, a large complex that facilitates this splicing process. By disrupting or modifying spliceosome activity, these activators can create an environment wherein the cell responds by enhancing FUSIP1 activity to maintain efficient RNA splicing.
Compounds like Isoginkgetin, E7107, and Spliceostatin A exhibit their influence by binding to specific components of the spliceosome, thereby altering its function. For instance, Spliceostatin A binds to SF3B1, a subunit of the spliceosome, leading the cell to possibly increase the activity of FUSIP1 as a compensatory response. Similarly, Pladienolide B and Herboxidiene target the SF3B complex and can induce a condition where FUSIP1 activity is favored or upregulated. Other compounds, such as 1-(1,4-Dimethyl-7-propyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperidin-4-amine, while not directly interacting with the spliceosome, modulate pre-mRNA splicing, and can shift the balance of splicing factors, leading to an enhanced role for FUSIP1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5′-O-Tritylthymidine | 7791-71-1 | sc-221064 | 1 g | $110.00 | ||
Its involvement in RNA processing might change the splicing dynamics, potentially favoring or activating FUSIP1. | ||||||